LCP1 correlates with immune infiltration: a prognostic marker for triple-negative breast cancer.

Shuaikang PanMengting WanHongwei JinRan NingJinguo Zhang Xinghua Han

Published in: BMC immunology (2024)

LCP1 may serve as a potential diagnostic and prognostic biomarker for TNBC, which was closely associated with immune cell infiltration, particularly M1 and M2 macrophages. Our findings may provide valuable insights into immunotherapeutic strategies for TNBC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
risk assessment
climate change
patient reported